南新制药：2025年度净利润约-1.37亿元

Group 1 - Company Nanjing New Pharmaceutical reported a revenue of approximately 142 million yuan for the year 2025, representing a year-on-year decrease of 46.09% [1] - The net profit attributable to shareholders of the listed company was a loss of approximately 137 million yuan [1] - The basic earnings per share showed a loss of 0.5006 yuan [1] Group 2 - The news highlights a significant shift in AI usage, with China's AI call volume surpassing that of the United States, leading to a surge in multiple sectors in the A-share market [1] - A well-known Wall Street analyst noted that China's computing power path is overturning traditional perceptions [1]